Kristina M. Deligiannidis, MD
Dr. Deligiannidis completed her undergraduate degrees and an Honors Scholars Research Program in Neuroscience and Behavior at the University of Massachusetts at Amherst. As a recipient of NIH pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the NIH/National Institutes of Child Health and Human Development (NIH/NICHD).
Dr. Deligiannidis completed additional research training at the National Institute of Mental Health (NIMH) and NICHD during medical school and residency. She received her medical degree from the University of Massachusetts Medical School and completed her psychiatry residency and chief residency in psychopharmacology research at UMass Medical School (UMMS)/UMass Memorial Health Care (UMMHC). Dr. Deligiannidis joined faculty at UMMS in October 2009 and is Board Certified by the American Board of Psychiatry and Neurology.
Dr. Deligiannidis is the Director of the Depression Specialty Clinic, a regional referral center at UMMHC that specializes in the evaluation and treatment of adult patients suffering from major depression, psychotic depression, treatment-resistant depression and bipolar depression.
Dr. Deligiannidis also evaluates and treats women in the Women’s Mental Health Specialty Clinic at UMMHC. She provides consultation and short-term treatment of women suffering from depression and anxiety during pregnancy or the post-partum period. Her expertise is focused on psychopharmacologic complementary/alternative treatments for depression/anxiety/stress during the perinatal period.
Dr. Deligiannidis conducts translational research in the causes of perinatal depression. She also conducts depression research on novel therapeutics. Her research interests include:
¨ Psychoneuroendocrinology (hypothalamic-pituitary-adrenal and gonadal axes, gonadal hormones and neuroactive steroids)
¨ Neuroimaging and neuroendocrine biomarkers of depression in women during perinatal period
¨ Gender differences in depression and treatment response
¨ Complementary and alternative/integrative treatments
Dr. Deligiannidis's research efforts have been nationally recognized. She is the recipient of: a 2013-2018 NIH K23 Career Development Award, 2014 American College of Neuropsychopharmacology (ACNP) Award, 2014-2016 NIH LRP Award, 2012 Research Career Development Institute (CDI) for Psychiatry Award, 2011 UMass Medical School Center for Clinical & Translational Science (CTSA) Pilot Grant, a UMMS Faculty Scholar Award, a 2011 Society for Biological Psychiatry (SOBP) Travel Scholarship Award, a 2010 Worcester Foundation for Biomedical Research Grant; a 2009 NIMH/NCDEU New Investigator Award, APA/APIRE Junior Investigator Awards (2008, 2009) and American Society of Clinical Psychopharmacology/NIMH Clinical Trials in Psychopharmacology Awards (2007, 2008). At UMass, she has received the Early Career Achievement Award in Science and Health (2013) and several teaching awards.
Dr. Deligiannidis actively participates in national scientific committees and gives scientific presentations locally, regionally and nationally. She is an appointed Young Investigator Member of the International Society of Psychoneuroendocrinology (ISPNE) and a member of the Society of Biological Psychiatry (SOBP), the Society of Behavioral Neuroendocrinology (SBE), the Organization for Human Brain Mapping (OHBM), and the American Society of Clinical Psychopharmacology (ASCP). She serves on the Board of Directors of ASCP and on the Editorial Board for the international journal, Acta Psychiatrica Scandinavica, Co-Chair of the Education Committees for both the ASCP and SOBP and is an Early Career Reviewer at NIH.